Replies to post #230 on MyMD Pharmaceuticals Inc (MYMD)

[leifsmith]

The FDA, in my opinion, as part of an attack motivated by the economic interest of their clients, major pharmaceutical companies, and by the political interests of anti-Republican politicians, had forced Star Scientific to take Anatabloc off the market. Rock Creek inherited the disastrous state of affairs and was unable to overcome the drag.

I don't recall the timeline very well and may be missing something. But I do recall that my friends and I, and some of our employees in my company, were never able to buy Anatabloc after Star stopped selling it.

If anyone reading this has a better or corrected explanation please help me relearn the history.

[leifsmith]

Although the molecules are, at one level, similar, at another more detailed level they are very different. Anatabloc has two six carbon rings, and MYMD-1 has one six carbon ring and one five carbon ring.

This is actually a major difference.

The biochemistry of living systems can be so sensitive that even a difference of a single sugar molecule in two human blood types can make infusion of the "wrong" blood fatal to the recipient. The "small" difference has big consequences.

Patrick Cox, an early researcher and writer on Anatabloc, has told me that the MYMD-1 molecule is significantly better than the Anatabloc molecule. It will be interesting to watch that difference become more clear.

I don't yet understand how what might be expected from the anatabine citrate molecule (Anatabloc) and the MYMD-1 molecule are not the same. The described effects seem to be the same. Maybe it's a difference in effectiveness? or are some health states addressed by MYMD-1 that Anatabloc could not touch?